GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia

GPR119 agonists have the ability to pharmacologically augment glucagon secretion, specifically in response to hypoglycemia in diabetic rodents, and whether this effect might serve to diminish the occurrence and severity of iatrogenic hypglycemia during intensive insulin therapy in patients with diabetes remains to be established.